Atlas Trials

Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation

Clinical trial NCT01697319 · TERMINATED

Trial details

NCT number
NCT01697319
Sponsor
BioMarin Pharmaceutical
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Mucopolysaccharidosis IVAMorquio A SyndromeMPS IVA
Start date
2012-08-01
Primary completion
2014-10-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.